Business Context and Reporting Period
Company: Maiden Holdings, Ltd.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2024
Business Overview: Maiden Holdings is a Bermuda-based holding company managing assets and capital primarily in the insurance and financial services sectors. The company is currently in a run-off phase for its historic reinsurance programs, specifically the AmTrust Reinsurance segment, and has ceased underwriting new prospective reinsurance risks. It maintains two reportable segments: Diversified Reinsurance and AmTrust Reinsurance. The company is actively pursuing strategic initiatives to divest its IIS (Insurance Intermediary Services) businesses and reposition its balance sheet by reducing alternative investments to strengthen liquidity.
Key Financial Metrics
| Metric (in thousands, except per share) | Three Months Ended Sept 30, 2024 | Nine Months Ended Sept 30, 2024 | Dec 31, 2023 (Balance Sheet) |
|---|---|---|---|
| Net Premiums Earned | $13,403 | $37,888 | — |
| Net Investment Income | $4,878 | $19,531 | — |
| Net Realized/Unrealized Investment Gains (Losses) | $(3,804) | $6,403 | — |
| Total Revenues | $14,477 | $63,868 | — |
| Total Expenses | $49,671 | $109,190 | — |
| Net Loss | $(34,468) | $(42,980) | — |
| Loss Per Share (Basic & Diluted) | $(0.35) | $(0.43) | — |
| Total Assets | — | — | $1,393,511 |
| Total Liabilities | — | — | $1,185,329 |
| Shareholders' Equity | — | — | $208,182 |
| Cash and Cash Equivalents | — | — | $109,965 |
| Senior Notes (Principal) | — | — | $262,361 |
Material Changes vs. Prior Comparable Period
- Net Loss Deterioration: Net loss for the nine months ended September 30, 2024, increased to $43.0 million from $17.8 million in the same period in 2023. This was driven by higher underwriting losses and lower investment income.
- Underwriting Loss: The underwriting loss for the nine months ended September 30, 2024, was $36.0 million, compared to $28.4 million in 2023. This increase was primarily due to adverse prior year loss development (PPD) of $25.1 million in 2024 versus $16.0 million in 2023.
- Investment Income Decline: Net investment income decreased by $9.6 million (32.9%) year-over-year for the nine-month period, largely due to lower interest income on funds withheld with AmTrust as claim payments settled the receivable balance, which was fully depleted by September 30, 2024.
- Foreign Exchange Impact: The company recorded foreign exchange losses of $3.9 million for the nine months ended September 30, 2024, compared to losses of $0.8 million in 2023, attributable to the weakening of the U.S. dollar against the euro and British pound.
- Balance Sheet Shifts: Total assets decreased by $125.4 million to $1.39 billion, primarily due to a $129.2 million reduction in funds withheld receivable and a $146.0 million reduction in loss reserves as liabilities run off.
Guidance, Outlook, Risks, and Unusual Items
- Strategic Repositioning: Management is actively reducing its alternative investment portfolio (down 18.0% year-to-date) to reposition the balance sheet and strengthen liquidity. The company is no longer writing new business in its IIS segment and is pursuing finality solutions for AmTrust liabilities not covered by retroactive reinsurance.
- AmTrust Loss Development: Significant adverse PPD continues in the AmTrust Reinsurance segment ($24.2 million for the nine months ended Sept 30, 2024). Approximately $22.5 million of this adverse development is recoverable under the Loss Portfolio Transfer and Adverse Development Cover (LPT/ADC) Agreement with Cavello Bay Reinsurance Limited and will be recognized as future GAAP income.
- European Hospital Liability Risk: The company is analyzing the impact of updated compensation tables in Italy on the European Hospital Liability Quota Share, which could significantly impact ultimate loss estimates. This exposure is not covered by the LPT/ADC Agreement.
- Capital Management: The company continues to repurchase common shares and senior notes. As of September 30, 2024, $68.7 million remained authorized for common share repurchases and $99.9 million for senior note repurchases.
- Legal Proceedings: A putative class action lawsuit regarding alleged inadequate loss reserves was granted summary judgment in favor of the company in December 2023; plaintiffs have appealed. The company believes the claims are without merit.
- Unusual Items: The company recognized a premium deficiency of $3.7 million in the AmTrust Reinsurance segment, accelerating the amortization of deferred acquisition costs.
Investor Verification Checklist
- LPT/ADC Agreement Coverage: Verify the extent to which adverse loss development in the AmTrust segment is covered by the Cavello agreement versus the portion that remains at risk (specifically European Hospital Liability).
- Alternative Investment Liquidity: Assess the impact of the company's strategy to liquidate alternative investments on future investment income and the timeline for redeployment of capital.
- Foreign Exchange Exposure: Monitor the company's unhedged exposure to the euro and British pound, given the significant foreign currency losses recorded in the current period.
- Reserve Adequacy: Review the updated loss reserve estimates for the European Hospital Liability Quota Share following the changes in Italian compensation tables.
- Debt Service Capacity: Confirm the sufficiency of dividends from subsidiaries (Maiden Reinsurance to Maiden NA) to service the $262.4 million in senior notes, particularly as investment income declines.